Latest News

CAMBRIDGE & LONDON, England — Broken String Biosciences, a genomics company driving development of the next generation of more precise, safe, and effective cell and gene therapies, today announced it has entered a research collaboration with the Francis Crick Institute, a world-leading biomedical discovery institute dedicated to understanding the biology...
Alfred Santiago the third needs your help. The 2-year-old was born with a rare congenital disorder where a part of his brain is shrinking over time. His father, Alfred Santiago Jr., who works and lives part-time in the Bronx, has found a California doctor who will perform a stem-cell surgery...
BROOKLYN, Mich.  – Full of life and full of love. That’s who four year-old Jaxon Meschke is. “All my friends! I love mom. I love dad and baby brother,” said four-year old Jaxon. But it’s his perseverance that stands out to his parents Brian and Chelsea Meschke most. “He really...
EATONS HILL — An Eatons Hill family knows the daily battles of managing life with cystic fibrosis. Alison and Ben Perkin are the proud parents of four children, two of whom have cystic fibrosis (CF), the most common incurable genetic condition that substantially shortens life expectancy. Mrs Perkin said her...
CAMBRIDGE, Mass. & BEIJING – BeiGene (NASDAQ: BGNE; HKEX: 06160) announced positive results from a planned interim analysis of the Phase 3 ALPINE trial comparing BRUKINSA® (zanubrutinib) against ibrutinib in adults with relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). BRUKINSA met the primary endpoint of the trial, demonstrating...
Digital communities have become support networks for patients of rare diseases, as well as professionals. They boost access to research, encourage advocacy, and aid evidence-gathering When Lucinda Andrews learned that her newborn son was only the 16th person in the world known to be diagnosed with an ultra-rare genetic disorder, she...